In this Issue
What Does the Future Hold?
Guest Chief Medical Editors’ Page
By Ali Azizzadeh, MD, FACS; and Dittmar Böckler, MD, PhD
Using detailed imaging analysis and dedicated software to identify subtle changes in endograft geometry within the aortic neck prior to late failure.
By Richte C.L. Schuurmann, PhD; Cornelis G. Vos, MD, PhD; and Jean-Paul P.M. de Vries, MD, PhD
The benefits and limitations of finite element analysis in patients with abdominal aortic aneurysms.
By Philipp Erhart, MD; Moritz Lindquist Liljeqvist, MD; Joy Roy, MD, PhD; T. Christian Gasser, PhD; and Dittmar Böckler, MD, PhD
The President of the German Society of Vascular Surgery and Vascular Medicine discusses Germany’s nationwide AAA screening program, the challenges and potential drawbacks to screening, and the use of monitoring devices in aortic health.
With Dittmar Böckler, MD, PhD
A discussion on the current landscape of genetics research related to diagnosing and treating aortic disease.
With Dianna M. Milewicz, MD, PhD
Prof. Loftus shares his thoughts on the impending publication of the UK’s NICE updated guidelines for abdominal aortic aneurysm treatment and the potential effects they may have on practice and patients.
With Ian M. Loftus, MD, FRCS
Insight into the creation and use of Aortica Corporation’s AortaFit software application to generate 3D-printed, patient-specific, fenestrated endograft templates for treating juxtarenal abdominal aortic aneurysms.
With Benjamin W. Starnes, MD, FACS
Exploring the role of three-dimensional printing in preprocedural planning and custom fenestration in physician-modified grafts to treat acute, complex abdominal and thoracoabdominal aortic pathologies.
By Daniela Branzan, MD; Andrej Schmidt, MD, PhD; Dirk Winkler, MD, PhD; Dierk Scheinert, MD, PhD; and Ronny Grunert, PhD
Experts contemplate necessary advancements in the next era of AAA management, including new imaging technology, an understanding of the role of genetics and genomics, and EVAR improvements.
With Juan Parodi, MD; Edward Y. Woo, MD; Shirling Tsai, MD; and Takao Ohki, MD
SUPERFICIAL VENOUS DISEASE UPDATE
Ask the Experts: Which Factors Have the Most Influence on Your Decision-Making Regarding the Treatment of Perforators?
Leading venous practitioners share their treatment algorithms for when it is appropriate to intervene on perforator veins and when it is not.
With Melvin Rosenblatt, MD; Sergio Gianesini, MD, PhD, FACS; Ellen D. Dillavou, MD, FACS; Thomas Proebstle, MD; and Kathleen Gibson, MD, FACS
Ask the Experts: If a Government Health Oversight Agency Offered You Full Funding for a Superficial Venous Trial, What Would You Study and Why?
Leading venous practitioners outline the trials that they believe are most urgently needed.
With Sarah Onida, BSc, MBBS, MRCS, PhD; Elna Masuda, MD; and Johann Chris Ragg, MD
The Immediate Past President of the American College of Phlebology discusses the recent change in the society’s name, as well as its continued efforts and evolving goals.
With Neil Khilnani, MD, FSIR, FACPh
Continuing Coverage: Paclitaxel in PAD
Dr. Katsanos discusses the methods and findings of his group’s meta-analysis, the patient-level data presented in response, and potential next steps.
Points of consensus, contention, and paths forward.
FEATURED TECHNOLOGYSponsored by Ra Medical Systems, Inc.
By Elias H. Kassab, MD, FACC, FSCAI, FACP, FASA, RPVI, FAHA, FSVM; Anna M. Leyson-Fiel, BSN, RN, CCRC; Frank Liegghio, BaS, RTR CV; and Andrew Kozak, RN, BASc
Drs. Glenn Hoots and Kiran Venkat Chunduri share their experience with the FlowTriever and ClotTriever Systems, respectively, and Drs. Mike Jolly and Nathan Saucier describe the evolution of their venous thromboembolism practices.